Quest Diagnostics (DGX) Tops Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $232.06 -5.24%
EPS Growth %: +10.0%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +10.0%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.98, $0.07 better than the analyst estimate of $1.91. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.26 billion.
GUIDANCE:
Quest Diagnostics sees FY2023 EPS of $8.40-$9.00, versus the consensus of $8.69. Quest Diagnostics sees FY2023 revenue of $8.83-9.03 billion, versus the consensus of $9.13 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Quest Diagnostics (DGX) PT Raised to $260 at Truist Securities
- Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
